Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06477497Not Yet Recruiting

The Application of Comprehensive Prevention and Treatment Strategy of Placenta Accreta Spectrum Disorders

Role: collaborator

NCT06322225Not Yet Recruiting

Establishment of Big Data Platform and Biobank for Colorectal Tubular Adenoma Lesions

Role: collaborator

NCT05814770Phase 4Not Yet Recruiting

Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism

Role: collaborator

NCT03847402Not ApplicableCompleted

The Early Integrated Intervention for Child Brain-developmental Disorders in China

Role: collaborator

All 4 trials loaded